Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8600)
All Articles published online
|
Publishing Process of This Article
|
Oct 10, 2014 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nguyen KSH, Neal JW, Wakelee H. Review of the current targeted therapies for non-small-cell lung cancer. World J Clin Oncol 2014; 5(4): 576-587 [PMID: 25302162 DOI: 10.5306/wjco.v5.i4.576] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i4/576.htm |
| Number | Citing Articles |
| 1 |
Kang Li, Jianxiang Liu, Mei Tian, Chunnan Piao, Jianlei Ruan, Ling Gao, Xuesong Qi, Gang Gao, Xu Su. The Role of CHMP4C on Proliferation in the Human Lung Cancer A549 Cells. Journal of Cancer Therapy 2015; 6(15): 1223 doi: 10.4236/jct.2015.615133
|
| 2 |
Xiaofen Pan, Zhixiu Lin, Danxian Jiang, Ying Yu, Donghong Yang, Hechao Zhou, Dechao Zhan, Sha Liu, Gang Peng, Zihong Chen, Zhonghua Yu. Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis. Oncology Letters 2019; doi: 10.3892/ol.2019.9888
|
| 3 |
Shaoyuan Wang, Xin Zheng, Yanbao Zhang, Pei Hu, Lieming Ding, Li Mao, Ji Jiang. Determination of BPI15086 and Its Metabolite in Human Plasma By Ultra-High Performance Liquid Chromatography–MS/MS and Its Application to a Pharmacokinetic Study. Bioanalysis 2019; 11(8): 773 doi: 10.4155/bio-2018-0307
|
| 4 |
Shinji Yamazaki, Mary E. Spilker, Paolo Vicini. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside. Expert Opinion on Drug Metabolism & Toxicology 2016; 12(3): 253 doi: 10.1517/17425255.2016.1141895
|
| 5 |
Masayoshi Yamaguchi. Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy. Cancers 2023; 15(22): 5489 doi: 10.3390/cancers15225489
|
| 6 |
Lindsey Eldridge, Aigul Moldobaeva, Qiong Zhong, John Jenkins, Michael Snyder, Robert H. Brown, Wayne Mitzner, Elizabeth M. Wagner. Bronchial Artery Angiogenesis Drives Lung Tumor Growth. Cancer Research 2016; 76(20): 5962 doi: 10.1158/0008-5472.CAN-16-1131
|
| 7 |
Barbara Rath, Maximilian Hochmair, Adelina Plangger, Gerhard Hamilton. Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines. Marine Drugs 2018; 16(10): 383 doi: 10.3390/md16100383
|
| 8 |
Hanna-Riikka Teppo, Ylermi Soini, Peeter Karihtala, Spencer Gibson. Reactive Oxygen Species‐Mediated Mechanisms of Action of Targeted Cancer Therapy. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/1485283
|
| 9 |
Mi Kim, Ji Jang, Chang Park, Taek-Keun Kim, Youn-Jae Kim, Junho Chung, Hyunbo Shim, In Nam, Jung Han, Sukmook Lee. A Human Antibody That Binds to the Sixth Ig-Like Domain of VCAM-1 Blocks Lung Cancer Cell Migration In Vitro. International Journal of Molecular Sciences 2017; 18(3): 566 doi: 10.3390/ijms18030566
|
| 10 |
Yong‐Hong Pan, Cai‐Yu Lin, Cong‐Hua Lu, Li Li, Yu‐Bo Wang, Heng‐Yi Chen, Yong He. Metformin synergistically enhances the antitumor activity of the third‐generation EGFR‐TKI CO‐1686 in lung cancer cells through suppressing NF‐κB signaling. The Clinical Respiratory Journal 2018; 12(12): 2642 doi: 10.1111/crj.12970
|
| 11 |
Mohammed Salah Ayoup, Yasmin Wahby, Hamida Abdel-Hamid, Marwa M. Abu-Serie, Sherif Ramadan, Assem Barakat, Mohamed Teleb, Magda M. F. Ismail. Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer. RSC Advances 2023; 13(40): 27722 doi: 10.1039/D3RA04029A
|
| 12 |
Etay Ziv, Jeremy C. Durack, Stephen B. Solomon. The Importance of Biopsy in the Era of Molecular Medicine. The Cancer Journal 2016; 22(6): 418 doi: 10.1097/PPO.0000000000000228
|
| 13 |
Robert G. Mennel. Precision Medicine: Hype or Hoax?. Baylor University Medical Center Proceedings 2015; 28(3): 397 doi: 10.1080/08998280.2015.11929290
|
| 14 |
Anders W. Erickson, Sunit Das. The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00797
|
| 15 |
Giovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, Valentina Zuco, Laura Gatti. Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents. European Journal of Medicinal Chemistry 2017; 142: 271 doi: 10.1016/j.ejmech.2017.07.062
|
| 16 |
Junhui Wang, Jianxin Chen. Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: a case report. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5352-7
|
| 17 |
Teodora Costea, Oana Cezara Vlad, Luminita-Claudia Miclea, Constanta Ganea, János Szöllősi, Maria-Magdalena Mocanu. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. International Journal of Molecular Sciences 2020; 21(2): 401 doi: 10.3390/ijms21020401
|
| 18 |
Hao Zhou, Linfeng Tang, Zeng-Fu Shang, Ping-Kun Zhou, Ming Li. PIG3 downregulation enhances the radiosensitivity of NSCLC cells by promoting G2/M cell cycle arrest and apoptosis. Radiation Medicine and Protection 2023; 4(1): 19 doi: 10.1016/j.radmp.2022.10.003
|
| 19 |
Benjamin J. Solomon, Federico Cappuzzo, Enriqueta Felip, Fiona H. Blackhall, Daniel B. Costa, Dong-Wan Kim, Kazuhiko Nakagawa, Yi-Long Wu, Tarek Mekhail, Jolanda Paolini, Jennifer Tursi, Tiziana Usari, Keith D. Wilner, Paulina Selaru, Tony S.K. Mok. Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014. Journal of Clinical Oncology 2016; 34(24): 2858 doi: 10.1200/JCO.2015.63.5888
|
| 20 |
Yiling Li, Linyang Huang, Yanchi Chen, Yixin Shi, Yiting Ze, Yang Yao. Irradiated Cell-Derived Exosomes Transmit Essential Molecules Inducing Radiation Therapy Resistance. International Journal of Radiation Oncology*Biology*Physics 2022; 113(1): 192 doi: 10.1016/j.ijrobp.2022.01.036
|
| 21 |
Ameen Abdulla Salahudeen, Manali I. Patel, Paul Baas, Walter J. Curran, Jeffrey D. Bradley, David R. Gandara, Glenwood D. Goss, Tony S. Mok, Suresh S. Ramalingam, Everett E. Vokes, Shakun M. Malik, Heather A. Wakelee. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe. Clinical Lung Cancer 2017; 18(1): 5 doi: 10.1016/j.cllc.2016.06.007
|
| 22 |
Dilip Narayanan, Osman A. B. S. M. Gani, Franz X. E. Gruber, Richard A. Engh. Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR. Journal of Cheminformatics 2017; 9(1) doi: 10.1186/s13321-017-0229-8
|
| 23 |
BO ZHOU, JUN NIE, WEIDONG YANG, CHENHONG HUANG, YE HUANG, HONGFEI ZHAO. Effect of hydrothorax EGFR gene mutation and EGFR-TKI targeted therapy on advanced non-small cell lung cancer patients. Oncology Letters 2016; 11(2): 1413 doi: 10.3892/ol.2015.4066
|
| 24 |
Si‐Yang Liu, Tony Mok, Yi‐Long Wu. Novel targeted agents for the treatment of lung cancer in China. Cancer 2015; 121(S17): 3089 doi: 10.1002/cncr.29522
|
| 25 |
Helei Hou, Xiaonan Yang, Jinping Zhang, Zhe Zhang, Xiaomei Xu, Xiaoping Zhang, Chuantao Zhang, Dong Liu, Weihua Yan, Na Zhou, Hongmei Zhu, Zhaoyang Qian, Zhuokun Li, Xiaochun Zhang. Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14962-0
|
| 26 |
Shanshan Chen, Ping Li, Rui Yang, Ruirui Cheng, Furui Zhang, Yuanyuan Wang, Xiaonan Chen, Qianqian Sun, Wenqiao Zang, Yuwen Du, Guoqiang Zhao, Guojun Zhang. microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0236-7
|
| 27 |
GIOVANNA ANTONELLI, MASSIMO LIBRA, VINCENZO PANEBIANCO, ALESSIA ERIKA RUSSO, FELICE VITO VITALE, PAOLO COLINA, ALESSANDRO D'ANGELO, ROSALBA ROSSELLO, FRANCESCO FERRAÙ. Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer. Oncology Letters 2016; 11(1): 3 doi: 10.3892/ol.2015.3901
|
| 28 |
Shasha Bai, Wenhao Wen, Xuenan Hou, Jiexiu Wu, Lang Yi, Yingkun Zhi, Yanjun Lv, Xiaoqin Tan, Liang Liu, Peixun Wang, Hua Zhou, Yan Dong. Inhibitory effect of sinomenine on lung cancer cells via negative regulation of α7 nicotinic acetylcholine receptor. Journal of Leukocyte Biology 2021; 109(4): 843 doi: 10.1002/JLB.6MA0720-344RRR
|
| 29 |
Wenxi Yu, Lina Tang, Feng Lin, Yang Yao, Zan Shen. Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis. Journal of Neuro-Oncology 2015; 125(2): 427 doi: 10.1007/s11060-015-1934-7
|
| 30 |
Yang Yang, Yanchao Deng, Xiangcui Chen, Jiahao Zhang, Yueming Chen, Huachao Li, Qipeng Wu, Zhicheng Yang, Luyong Zhang, Bing Liu. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism. Toxicology Letters 2018; 295: 88 doi: 10.1016/j.toxlet.2018.05.033
|
| 31 |
R.A. Ward, M.R.V Finlay. Comprehensive Medicinal Chemistry III. 2017; : 1 doi: 10.1016/B978-0-12-409547-2.12448-5
|
| 32 |
Shanthi Kanthala, Sandeep Pallerla, Seetharama Jois. Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors. Future Oncology 2015; 11(5): 865 doi: 10.2217/fon.14.312
|
| 33 |
Kang Li, Jianxiang Liu, Mei Tian, Gang Gao, Xuesong Qi, Yan Pan, Jianlei Ruan, Chunxu Liu, Xu Su. CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation. International Journal of Molecular Sciences 2015; 17(1): 18 doi: 10.3390/ijms17010018
|
| 34 |
Lu Wang, Xin Zheng, Weicong Wang, Pei Hu, Ji Jiang. An LC–MS/MS method for quantification of AC0010, a novel mutant-selective epidermal growth factor receptor (EGFR) inhibitor, and its metabolites in human plasma and the application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2017; 141: 9 doi: 10.1016/j.jpba.2017.03.051
|
| 35 |
Eleanor Jones, Christos Mikropoulos, Mahbubl Ahmed. The Future of Immunotherapy in the Treatment of Lung Cancer. Lung Cancer Management 2015; 4(2): 57 doi: 10.2217/lmt.15.2
|
| 36 |
Gaetano Romano. Tumor markers currently utilized in cancer care. Materials and Methods 2015; 5 doi: 10.13070/mm.en.5.1456
|
| 37 |
Robert G. Mennel. Precision Medicine: Hype or Hope?. Baylor University Medical Center Proceedings 2015; 28(3): 397 doi: 10.1080/08998280.2015.11929291
|
| 38 |
Carlo Dietz, Manfred Infanger, Alexander Romswinkel, Florian Strube, Armin Kraus. Apoptosis Induction and Alteration of Cell Adherence in Human Lung Cancer Cells under Simulated Microgravity. International Journal of Molecular Sciences 2019; 20(14): 3601 doi: 10.3390/ijms20143601
|
| 39 |
Rui Xiong, Ruyuan He, Bohao Liu, Wenyang Jiang, Bo Wang, Ning Li, Qing Geng, Manuela Curcio. Ferroptosis: A New Promising Target for Lung Cancer Therapy. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/8457521
|
| 40 |
Kumar Prabhash, Daniel Shao Weng Tan, Ross A. Soo, Piyada Sitthideatphaiboon, Yuh Min Chen, Pei Jye Voon, Elisna Syahruddin, Sojung Chu, Reto Huggenberger, Byoung-Chul Cho. Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1117348
|
| 41 |
RANRAN KONG, JIE FENG, YUEFENG MA, BIN ZHOU, SHAOMIN LI, WEI ZHANG, JIANTAO JIANG, JIN ZHANG, ZHE QIAO, TING ZHANG, QUANJIN ZANG, XIJING HE. Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1 signaling pathway. Oncology Reports 2016; 35(4): 2306 doi: 10.3892/or.2016.4552
|
| 42 |
Rod Balhorn, Monique Cosman Balhorn, Karuppiah Balakrishnan, Robert B. Rebhun. The small molecule antibody mimic SH7139 targets a family of HLA-DRs expressed by B-cell lymphomas and other solid cancers. Journal of Drug Targeting 2020; 28(10): 1124 doi: 10.1080/1061186X.2020.1787418
|
| 43 |
Srivatsava Naidu, Lei Shi, Peter Magee, Justin D. Middleton, Alessandro Laganá, Sudhakar Sahoo, Hui Sun Leong, Melanie Galvin, Kristopher Frese, Caroline Dive, Vincenza Guzzardo, Matteo Fassan, Michela Garofalo. PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14843-6
|
| 44 |
Jianhong Zuo, Meiling Wen, Mingsheng Lei, Xiaojun Xiao, Zhigang Liu. WITHDRAWN: PLGA-Der p1 Vaccine Inhibited Tumor Growth in a Murine Model of Lung Cancer. Archives of Medical Research 2015; doi: 10.1016/j.arcmed.2015.12.005
|
| 45 |
Sanja Mijatović, Ana Savić-Radojević, Marija Plješa-Ercegovac, Tatjana Simić, Ferdinando Nicoletti, Danijela Maksimović-Ivanić. The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors. Antioxidants 2020; 9(5): 374 doi: 10.3390/antiox9050374
|
| 46 |
T Wang, T Yan, S Ma, K Wang, J Wang, J Song, W He, J Bai, L Jin. The efficacy and safety of preoperative chemotherapy for patients with nonsmall cell lung cancer: A meta-analysis. Indian Journal of Cancer 2017; 54(1): 223 doi: 10.4103/ijc.IJC_60_17
|
| 47 |
Guler Yavas, Cagdas Yavas. Targeted therapy combined with thoracic radiotherapy for non-small cell lung cancer. Journal of Radiation Oncology 2019; 8(1): 1 doi: 10.1007/s13566-019-00379-x
|
| 48 |
Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin, Panagiotis Papageorgis. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers 2021; 13(17): 4363 doi: 10.3390/cancers13174363
|